Ignite Creation Date:
2024-05-05 @ 9:16 PM
Last Modification Date:
2024-10-26 @ 10:01 AM
Study NCT ID:
NCT00842855
Status:
COMPLETED
Last Update Posted:
2011-02-07
First Post:
2009-02-11
Brief Title:
Partial Response to PPI Treatment The Cost to Society and the Burden to the Patient - a Study in France
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Partial Response to PPI Treatment The Cost to Society and the Burden to the Patient
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REMAIN
Brief Summary:
The purpose of this study is to describe common treatment pathways to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None